Detalhe da pesquisa
1.
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
J Transl Med
; 18(1): 77, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054505
2.
Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.
Scand J Gastroenterol
; 55(6): 725-731, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32543919
3.
Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma.
Scand J Gastroenterol
; 55(1): 82-89, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31917931
4.
Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer.
Scand J Gastroenterol
; 54(2): 246-251, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880498
5.
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma.
Scand J Gastroenterol
; 54(1): 95-100, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663442
6.
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.
World J Surg Oncol
; 17(1): 29, 2019 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30736807
7.
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine.
Scand J Gastroenterol
; 52(5): 595-600, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270046
8.
Conditionally immortalized human pancreatic stellate cell lines demonstrate enhanced proliferation and migration in response to IGF-I.
Exp Cell Res
; 330(2): 300-310, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25304103